148 related articles for article (PubMed ID: 11274729)
1. Frequency of CCR5 gene 32-basepair deletion in Chilean HIV-1 infected and non-infected individuals.
Desgranges C; Carvajal P; Afani A; Guzman MA; Sasco A; Sepulveda C
Immunol Lett; 2001 Mar; 76(2):115-7. PubMed ID: 11274729
[TBL] [Abstract][Full Text] [Related]
2. Frequency of the CCR5 gene 32-basepair deletion in Hispanic Mexicans.
Salas-Alanis JC; Mellerio JE; Ashton GH; McGrath JA
Clin Exp Dermatol; 1999 Mar; 24(2):127-9. PubMed ID: 10233669
[TBL] [Abstract][Full Text] [Related]
3. Decreased susceptibility of peripheral blood mononuclear cells from individuals heterozygous for a mutant CCR5 allele to HIV infection.
Kim A; Pettoello-Mantovani M; Goldstein H
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Oct; 19(2):145-9. PubMed ID: 9768623
[TBL] [Abstract][Full Text] [Related]
4. Distribution of the HIV resistance CCR5-Delta32 allele among Egyptians and Syrians.
Salem AH; Batzer MA
Mutat Res; 2007 Mar; 616(1-2):175-80. PubMed ID: 17166523
[TBL] [Abstract][Full Text] [Related]
5. Association of heterozygous CCR5Δ32 deletion with survival in HIV-infection: A cohort study.
Ruiz-Mateos E; Tarancon-Diez L; Alvarez-Rios AI; Dominguez-Molina B; Genebat M; Pulido I; Abad MA; Muñoz-Fernandez MA; Leal M
Antiviral Res; 2018 Feb; 150():15-19. PubMed ID: 29221798
[TBL] [Abstract][Full Text] [Related]
6. Role of the genetic variant CCR5Δ32 in HBV infection and HBV/HIV co-infection.
Ellwanger JH; Kulmann-Leal B; Wolf JM; Michita RT; Simon D; Lunge VR; Chies JAB
Virus Res; 2020 Feb; 277():197838. PubMed ID: 31837381
[TBL] [Abstract][Full Text] [Related]
7. CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. French Pediatric HIV Infection Study Group.
Misrahi M; Teglas JP; N'Go N; Burgard M; Mayaux MJ; Rouzioux C; Delfraissy JF; Blanche S
JAMA; 1998 Jan; 279(4):277-80. PubMed ID: 9450710
[TBL] [Abstract][Full Text] [Related]
8. Frequency of CCR5 gene 32-basepair deletion in Croatian normal population.
Ristić S; Starcević Cizmarević N; Brajenović-Milić B; Crnić-Martinović M; Kapović M
Croat Med J; 2005 Aug; 46(4):693-4. PubMed ID: 16100775
[TBL] [Abstract][Full Text] [Related]
9. Genotype and allele frequency of a 32-base pair deletion mutation in the CCR5 gene in various ethnic groups: absence of mutation among Asians and Pacific Islanders.
Lu Y; Nerurkar VR; Dashwood WM; Woodward CL; Ablan S; Shikuma CM; Grandinetti A; Chang H; Nguyen HT; Wu Z; Yamamura Y; Boto WO; Merriwether A; Kurata T; Detels R; Yanagihara R
Int J Infect Dis; 1999; 3(4):186-91. PubMed ID: 10575146
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and the role of CCR5Δ32 heterozygosity in disease progression in HIV positive patients in the Czech Republic.
Sácká L; Hodek J; Machala L; Malý M; Weber J
Epidemiol Mikrobiol Imunol; 2019; 68(3):138-143. PubMed ID: 31914779
[TBL] [Abstract][Full Text] [Related]
11. Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.
Apostolakis S; Baritaki S; Krambovitis E; Spandidos DA
J Clin Virol; 2005 Dec; 34(4):310-4. PubMed ID: 16286055
[TBL] [Abstract][Full Text] [Related]
12. CCR5Delta32 genotypes in a German HIV-1 seroconverter cohort and report of HIV-1 infection in a CCR5Delta32 homozygous individual.
Oh DY; Jessen H; Kücherer C; Neumann K; Oh N; Poggensee G; Bartmeyer B; Jessen A; Pruss A; Schumann RR; Hamouda O
PLoS One; 2008 Jul; 3(7):e2747. PubMed ID: 18648518
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of the CCR5Delta32 HIV-resistance mutation among Estonian HIV type 1-infected individuals.
Adojaan M; Mölder T; Männik A; Kivisild T; Villems R; Krispin T; Ustav M
AIDS Res Hum Retroviruses; 2007 Feb; 23(2):193-7. PubMed ID: 17331026
[TBL] [Abstract][Full Text] [Related]
14. The coreceptor mutation CCR5Delta32 influences the dynamics of HIV epidemics and is selected for by HIV.
Sullivan AD; Wigginton J; Kirschner D
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10214-9. PubMed ID: 11517319
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of the 32 bp deletion in the CCR5 chemokine receptor gene in people from Moscow, infected with HIV-1].
Shadrina MI; Kapylov VM; Miloserdova OV; Slominskiĭ PA; Limborskaia SA
Genetika; 2000 May; 36(5):718-20. PubMed ID: 10867893
[TBL] [Abstract][Full Text] [Related]
16. Restriction of HIV type 1 infection in macrophages heterozygous for a deletion in the CC-chemokine receptor 5 gene.
Ometto L; Zanchetta M; Cabrelle A; Esposito G; Mainardi M; Chieco-Bianchi L; De Rossi A
AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1441-52. PubMed ID: 10555107
[TBL] [Abstract][Full Text] [Related]
17. The CCR5 receptor acts as an alloantigen in CCR5Delta32 homozygous individuals: identification of chemokineand HIV-1-blocking human antibodies.
Ditzel HJ; Rosenkilde MM; Garred P; Wang M; Koefoed K; Pedersen C; Burton DR; Schwartz TW
Proc Natl Acad Sci U S A; 1998 Apr; 95(9):5241-5. PubMed ID: 9560260
[TBL] [Abstract][Full Text] [Related]
18. The frequency of CCR5Delta32 and CCR2-64I in southern Iranian normal population.
Gharagozloo M; Doroudchi M; Farjadian S; Pezeshki AM; Ghaderi A
Immunol Lett; 2005 Jan; 96(2):277-81. PubMed ID: 15585333
[TBL] [Abstract][Full Text] [Related]
19. Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells.
Agrawal L; Lu X; Qingwen J; VanHorn-Ali Z; Nicolescu IV; McDermott DH; Murphy PM; Alkhatib G
J Virol; 2004 Mar; 78(5):2277-87. PubMed ID: 14963124
[TBL] [Abstract][Full Text] [Related]
20. Absence of the deltaccr5 mutation in indigenous populations of the Brazilian Amazon.
Leboute AP; de Carvalho MW; Simões AL
Hum Genet; 1999 Nov; 105(5):442-3. PubMed ID: 10598810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
